Previous
Previous

Nature feature: “Equitable Drug Access: Small-Scale Manufacturing Units Can Help,” co-written by RSV Global Access Fellows Taylor Rose and Anthony Bogachev

Next
Next

The Chronicle of Philanthropy feature on RSV’s Philanthropy Model, “A New Business-Charity Model Could Help Philanthropists Invest Their Money More Effectively” by Lindsay Androski, RSV CEO